AstraZeneca PLCHeart disease drug Wainua failed to meet target in late-stage trial.
AstraZeneca tumbled 8% in premarket trading after its heart disease drug Wainua failed to meet its target in a late-stage clinical trial. PepsiCo fell 1% after reporting mixed second-quarter results, with adjusted earnings of $2.20 per share missing the $2.21 estimate from analysts polled by LSEG, while revenue of $24.18 billion topped the $23.95 billion consensus. Salesforce shed 4% following a KeyBanc downgrade to sector weight from overweight, with the firm citing difficulty finding evidence of future upside. Stellantis slid 2% after JPMorgan downgraded the Jeep parent to neutral from overweight, saying it needs 14 months to reap turnaround benefits. Levi Strauss dropped 4% after issuing third-quarter EPS guidance of 34 to 36 cents, below the 38 cents expected by FactSet, despite beating second-quarter expectations on both top and bottom lines. AZZ jumped 6% after reporting quarterly earnings of $1.85 per share, exceeding the $1.69 FactSet consensus, with revenue of $448.5 million also above the $434.6 million forecast. Cerebras Systems moved nearly 7% higher after announcing a major European expansion, bringing its first European data center capacity online by year-end and planning to expand total capacity to 2000 megawatts in 2027. Costco lost nearly 2% after reporting decelerating comparable sales growth of 8.8% in June, down from 12.5% in May.
AstraZeneca PLCHeart disease drug Wainua failed to meet target in late-stage trial.
Gilead Sciences Inc
Cerebras Systems Inc. Class A Common StockCerebras announced a major European expansion, bringing its first European data center capacity online by year-end and planning to expand total capacity to 2000 megawatts in 2027.
Salesforce.com IncKeyBanc downgrade to sector weight citing difficulty finding evidence of future upside.
Costco Wholesale CorpCostco reported decelerating comparable sales growth of 8.8% in June, down from 12.5% in May.
PepsiCo IncMixed Q2 results with adjusted EPS miss of $2.20 vs $2.21 estimate.
AZZ IncorporatedAZZ reported quarterly earnings of $1.85 per share, exceeding the $1.69 consensus, with revenue also above forecasts.
Levi Strauss & Co Class AQ3 EPS guidance of 34-36 cents below 38 cents consensus.
Stellantis NVJPMorgan downgrade to neutral, saying it needs 14 months to reap turnaround benefits.